Cite
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
MLA
Basile, Umberto, et al. “Assessment of Free Light Chains in HCV-Positive Patients with Mixed Cryoglobulinaemia Vasculitis Undergoing Rituximab Treatment.” Liver International : Official Journal of the International Association for the Study of the Liver, vol. 35, no. 9, Sept. 2015, pp. 2100–07. EBSCOhost, https://doi.org/10.1111/liv.12829.
APA
Basile, U., Gragnani, L., Piluso, A., Gulli, F., Urraro, T., Dell’Abate, M. T., Torti, E., Stasi, C., Monti, M., Rapaccini, G. L., & Zignego, A. L. (2015). Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment. Liver International : Official Journal of the International Association for the Study of the Liver, 35(9), 2100–2107. https://doi.org/10.1111/liv.12829
Chicago
Basile, Umberto, Laura Gragnani, Alessia Piluso, Francesca Gulli, Teresa Urraro, Maria T Dell’Abate, Eleonora Torti, et al. 2015. “Assessment of Free Light Chains in HCV-Positive Patients with Mixed Cryoglobulinaemia Vasculitis Undergoing Rituximab Treatment.” Liver International : Official Journal of the International Association for the Study of the Liver 35 (9): 2100–2107. doi:10.1111/liv.12829.